UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings
Boston Scientific Corporation (NYSE:BSX) ranks among the best long-term stocks to buy according to D. E. Shaw.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 9,799,040 | $956,680,277 | +31% | 0.97% |
| 2. | D E Shaw D. E. Shaw | 8,910,355 | $869,917,959 | +32% | 0.49% |
| 3. | Citadel Investment Group Ken Griffin | 8,906,245 | $869,516,699 | +65% | 0.13% |
| 4. | Fisher Asset Management Ken Fisher | 8,461,025 | $826,049,958 | +10% | 0.3% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 8,367,398 | $816,909,067 | +29% | 0.52% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | $1,049,450.00 | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | $357.50 | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | $834.00 | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | $740.08 | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $98.28 | 12,891 | $1,266,977.75 | 24,134 | 2025-11-06 | Filing | |
| $99.14 | 29,472 | $2,921,895.34 | 178,342 | 2025-11-03 | Filing | |
| $99.76 | 16,928 | $1,688,749.13 | 207,814 | 2025-11-03 | Filing | |
| $100.75 | 3,600 | $362,693.16 | 224,742 | 2025-11-03 | Filing | |
| $102.24 | 2,901 | $296,598.82 | 24,134 | 2025-10-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 145,175,869 | $14,173,520,098 | 0.25% | |
| 2. | 138,249,447 | $13,497,293,511 | 0.2% | |
| 3. | 99,477,701 | $9,712,007,926 | 0.5% | |
| 4. | 64,925,564 | $6,338,682,813 | 0.22% | |
| 5. | 33,869,041 | $3,306,634,494 | 0.22% |
News See All
9 Best Long-Term Stocks to Buy According to D. E. Shaw
David E. Shaw, a Stanford University alumnus, is among of the hedge fund managers who have mastered the complexities of quant trading and routinely generating significant returns.
Boston Scientific (BSX) Fell Amid Rising Competition
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?
Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC.
13 Best Stocks to Buy According to Citadel LLC
Citadel LLC (formerly known as Citadel Investment Group) is known as one of the most successful and profitable alternative asset managers.
10 Best Stocks to Buy for High Returns Heading into 2026
On October 27, Nicolas Janvier, Head of North America Equities at Columbia Threadneedle Investments, joined CNBC television for an interview.
Boston Scientific Corporation (NYSE:BSX) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Boston Scientific Third Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained
Boston Scientific Corporation (NYSE:BSX) ranks among the best medical device stocks to invest in.
12 Best Medical Device Stocks to Invest In Now
As chronic diseases like diabetes and cancer become more common, medical device technology is becoming increasingly innovative.
What Makes Boston Scientific Corporation (BSX) an Investment Choice?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.